French pharma giant Sanofi announced Tuesday it was halting trials for its rheumatoid arthritis drug Kevzara after it failed to prove an effective treatment for Covid-19, reports Radio France Internationale.
You are a subscriber
Login
If you are not already a subscriber,
subscribe here
Choose a subscription offer and create your account to read all content on Mediapart
Create your account